Finally, the use of a pan-inhibitor of Aurora kinases, danusertib, promoted cellular apoptosis and autophagy, and inhibited the EMT in breast cancer cells, via modulation of p38 MAPK/Erk 1/2/Akt/mTOR signaling pathways, making this a promising anticancer treatment for breast cancer [49]. Here, AKT1 is linked to breast cancer.